Aslan Fred — SEC insider filings

SEC reporting owner CIK 1909362. 17 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2024-07-22 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Artiva Biotherapeutics, Inc. (ARTV)Chief Executive Officer, Director17—11 legs · 440,103 sh · $2,772,82619

Insider filings — Aslan Fred

FiledFormIssuerReported transactionsSource
2026-11-184Artiva Biotherapeutics, Inc. (ARTV)Sale (S): 119,771 @ $3.91EDGAR
2026-11-034Artiva Biotherapeutics, Inc. (ARTV)Sale (S): 62,178 @ $4.18EDGAR
2026-10-074Artiva Biotherapeutics, Inc. (ARTV)Sale (S): 23,463 @ $7.20EDGAR
2026-10-064Artiva Biotherapeutics, Inc. (ARTV)Sale (S): 61,696 @ $6.84EDGAR
2026-09-154Artiva Biotherapeutics, Inc. (ARTV)Grant/award (A): 110,000 @ $0 · Grant/award (A): 315,000 (derivative) @ $0EDGAR
2026-09-144Artiva Biotherapeutics, Inc. (ARTV)Grant/award (A): 45,000 @ $0 · Grant/award (A): 155,000 (derivative) @ $0EDGAR
2026-09-094Artiva Biotherapeutics, Inc. (ARTV)Sale (S): 23,429 @ $10.92EDGAR
2026-09-044Artiva Biotherapeutics, Inc. (ARTV)Sale (S): 61,888 @ $11.16EDGAR
2026-05-194Artiva Biotherapeutics, Inc. (ARTV)Sale (S): 27,116 @ $9.01EDGAR
2026-02-184Artiva Biotherapeutics, Inc. (ARTV)Grant/award (A): 366,850 @ $0 · Tax withholding (F): 14,600 @ $4EDGAR
2025-12-154Artiva Biotherapeutics, Inc. (ARTV)Sale (S): 3,187 @ $6EDGAR
2025-12-124Artiva Biotherapeutics, Inc. (ARTV)Grant/award (A): 869,136 @ $0 · Disposition to issuer (D): 100,577 (derivative) · Disposition to issuer (D): 51,463 (derivative) · Disposition to issuer (D): 257,319 (derivative) · Disposition to issuer (D): 26,450 (derivative) · Disposition to issuer (D): 113,999 (derivative) · +1 moreEDGAR
2025-11-174Artiva Biotherapeutics, Inc. (ARTV)Tax withholding (F): 6,347 @ $3.25 · Sale (S): 6,375 @ $3.38EDGAR
2025-10-174Artiva Biotherapeutics, Inc. (ARTV)Sale (S): 25,500 @ $6EDGAR
2025-08-184Artiva Biotherapeutics, Inc. (ARTV)Tax withholding (F): 4,472 @ $2.13 · Sale (S): 25,500 @ $2.73 · Tax withholding (F): 4,472 @ $2.75EDGAR
2025-03-074Artiva Biotherapeutics, Inc. (ARTV)Grant/award (A): 200,000 @ $0EDGAR
2024-07-224Artiva Biotherapeutics, Inc. (ARTV)Grant/award (A): 228,905 @ $0 · Grant/award (A): 343,811 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1909362 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs